Allianz Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Allianz Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-33,432	Closed	-$2.59M	–	2566
2020 Q1	$2.59M	Buy	33,432 +998	+3%	+$88.4K	﹤0.01%	1432
2019 Q4	$3.08M	Sell	32,434 -45,130	-58%	-$3.9M	﹤0.01%	1693
2019 Q3	$5.91M	Buy	+77,564	New	+$6.45M	0.01%	1364
2018 Q2	–	Sell	-8,500	Closed	-$746K	–	2728
2018 Q1	$746K	Buy	+8,500	New	+$776K	﹤0.01%	2294
2016 Q1	–	Sell	-20,900	Closed	-$1.47M	–	2604
2015 Q4	$1.47M	Hold	20,900	–	–	﹤0.01%	1837
2015 Q3	$1.3M	Sell	20,900 -4,600	-18%	-$363K	﹤0.01%	1731
2015 Q2	$2.14M	Hold	25,500	–	–	﹤0.01%	1678
2015 Q1	$1.92M	Buy	+25,500	New	+$1.78M	﹤0.01%	1549

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Allianz Asset Management's XBI Position: Q2 2020 in Review

Allianz Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2020, closing a stake of 33,432 shares — an estimated $2.59M sold.

Allianz Asset Management first reported a position in XBI in Q1 2015 and held it in 8 quarters. The position peaked at $5.91M in Q3 2019. 525 funds tracked by Wall St. Rank hold XBI as of Q2 2020.

Allianz Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2020 after selling out during the quarter.
Allianz Asset Management sold 33,432 State Street SPDR S&P Biotech ETF shares in Q2 2020, an estimated $2.59M.
Allianz Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 8 quarters.
Allianz Asset Management's State Street SPDR S&P Biotech ETF position peaked at $5.91M in Q3 2019.
525 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.